Insights on stocks, by experts you follow.

Pulse

• The semiconductor sell-off is the main story. Fears of Chinese chip supply, AI’s circular financing, and memory oversupply wiped over $500B from the sector, according to @amitisinvesting. The KOSPI triggered a circuit breaker, adding to global tech jitters.
• A rotation is on full display. Software and fintech names are rallying as chips fall. @biotech2k1 calls it the “chip wreck” and notes software ETFs rise when the $SOXX drops. @amitisinvesting and @ConnorJBates_ both flag the shift.
• Sentiment is split. Some are using bounces to dump positions (@biotech2k1 sold $TQQQ to dip-buyers), while others ask whether the sell-off is near a bottom or turning into something bigger (@ckcapitalxx).
• Macro anxiety adds pressure. Citadel reportedly expects the Fed to hike rates this week, per @amitisinvesting’s recap, keeping risk appetites in check.

Tickers to watch

• $MIAX — @ckcapitalxx lays out a detailed bull case. The exchange makes more money when volatility spikes. It also has a recurring, high-margin connectivity business (up 45%) and a mostly ignored 10% stake in a prediction-market venture with $HOOD that he sees as a big potential bonus.
• $AMKR / $FORM — @ckcapitalxx highlights quiet strength in chip testing and packaging. $AMKR signed a 10-year TSMC deal and a $1.5B Nvidia prepay to lock in capacity. $FORM just posted record revenue and strong HBM-related demand. Both report earnings this week.
• $MU / $SOXX — @ConnorJBates_ calls the $MU chart “the most important in the market,” showing a bearish head-and-shoulders pattern. He notes such setups have often become great long trades in the past, but the current level is a key test. The broader semi complex remains the market’s fulcrum.
• $PLTR — CEO Alex Karp is pushing “sovereign AI,” arguing companies must own the AI value they create instead of renting tools that might later copy their business. @amitisinvesting’s recap suggests the narrative is picking up steam as the next AI wave.
• $IMAX / $CNK — @asklivermore points out the movie industry is quietly having its best year in a decade. He sees IMAX as the premium play and Cinemark as the healthiest chain, with price charts starting to look promising.
• $TENX — Canaccord started coverage with a Buy and a $35 price target, per @biostocks. A small biotech with fresh analyst support.

Also notable

• @ConnorJBates_ compiled 12 froth signals from the recent top — including celebrity stock promoters and record Korean leverage — as a warning for future cycles.
• The Fed decision is a wildcard. @artinmemes notes that a surprise rate hike (Citadel’s call) could deal a heavy blow to stocks, though futures price only a modest chance.